Letter: The Prognostic Role of IGF-1 in Chronic Liver Disease-Authors' Reply

被引：0
|
作者：
Hartl, Lukas [1 ,2 ,3 ]
Schwarz, Michael [1 ,2 ]
Simbrunner, Benedikt [1 ,2 ,3 ,4 ]
Jachs, Mathias [1 ,2 ,3 ]
Wolf, Peter [5 ]
Bauer, David Josef Maria [1 ,2 ]
Scheiner, Bernhard [1 ,2 ,3 ]
Balcar, Lorenz [1 ,2 ,3 ]
Semmler, Georg [1 ,2 ,3 ]
Hofer, Benedikt Silvester [1 ,2 ,3 ,4 ]
Dominik, Nina [1 ,2 ,3 ]
Marculescu, Rodrig [6 ]
Trauner, Michael [1 ,3 ]
Mandorfer, Mattias [1 ,2 ,3 ]
Reiberger, Thomas [1 ,2 ,3 ,4 ]
机构：
[1] Med Univ Vienna, Dept Med 3, Div Gastroenterol & Hepatol, Vienna, Austria
[2] Med Univ Vienna, Dept Med 3, Div Gastroenterol & Hepatol, Vienna Hepat Hemodynam Lab, Vienna, Austria
[3] Med Univ Vienna, Dept Med 3, Div Gastroenterol & Hepatol, Clin Res Grp MOTION, Vienna, Austria
[4] Med Univ Vienna, Christian Doppler Lab Portal Hypertens & Liver Fib, Vienna, Austria
[5] Med Univ Vienna, Dept Med 3, Div Endocrinol, Vienna, Austria
[6] Med Univ Vienna, Dept Lab Med, Vienna, Austria
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2025年 / 61卷 / 01期
关键词：
D O I：
10.1111/apt.18368
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：228 / 229
页数：2
相关论文
共 50 条
  • [31] Editorial: treating strictures in inflammatory bowel disease-authors' reply
    Rieder, Florian
    Feagan, Brian G.
    Jairath, Vipul
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (11-12) : 1313 - 1314
  • [32] Letter: the effect of anti-COVID-19 treatment on the outcome of patients with inflammatory bowel disease-authors' reply
    Hadi, Yousaf
    Kochhar, Gursimran S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (01) : 179 - 179
  • [33] Letter: Meta-Analysis: Prevalence of Frailty and Associated Adverse Events in Inflammatory Bowel Disease-Authors' Reply
    Carbery, Isabel
    Todd, Oliver
    Selinger, Christian P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025, 61 (04) : 746 - 747
  • [34] Editorial: an elastography-based two-step approach to detect NAFLD with compensated advanced chronic liver disease-authors' reply
    Zhou, Yu-Jie
    Zheng, Ming-Hua
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (04) : 517 - 518
  • [35] Editorial: towards an understanding of increased mortality in coeliac disease-authors' reply
    Schneider, Carolin V.
    Strnad, Pavel
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (05) : 656 - 656
  • [36] Towards optimal thiopurine therapy for inflammatory bowel disease-authors' reply
    Vasudevan, Abhinav
    Con, Danny
    van Langenberg, Daniel R.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (06) : 794 - 794
  • [37] Editorial: time to eat? Skipping breakfast in metabolic-associated fatty liver disease-Authors' reply
    Xie, Jiarong
    Xu, Lei
    Xu, Chengfu
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (04) : 494 - 494
  • [38] Letter: predictive role of magnetic resonance elastography in chronic liver disease-still a long way to go. Authors' reply
    Tamaki, Nobuharu
    Higuchi, Mayu
    Kurosaki, Masayuki
    Izumi, Namiki
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (05) : 622 - 623
  • [39] CLINICALLY EVIDENT PORTAL HYPERTENSION ASSOCIATED WITH LOW IGF-1 IN CHILDREN WITH CHRONIC LIVER DISEASE
    Whitehead, Bridget
    Mohammad, Saeed
    Kelly, Susan
    Josefson, Jami
    Mithal, Leena B.
    Alonso, Estella M.
    HEPATOLOGY, 2020, 72 : 1087 - 1087
  • [40] Reply to: "Prognostic role of systemic inflammatory biomarkers in advanced chronic liver disease"
    Costa, Dalila
    Simbrunner, Benedikt
    Reiberger, Thomas
    JOURNAL OF HEPATOLOGY, 2021, 74 (04) : 1000 - 1001
12345